Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited completed a share repurchase on November 21, 2025, buying back 348,400 ordinary H shares on the exchange. The shares were acquired at prices ranging from HK$5.24 to HK$5.29, with a volume-weighted average price of HK$5.2587, totaling HK$1,832,116. These shares are designated to be held as treasury shares, increasing the company's treasury share count from 26,034,400 to 26,382,800.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 348,400, representing 0.0077% of the existing issued shares before the event. The closing balance of issued shares (excluding treasury shares) now stands at 4,495,949,524. The total number of issued shares remains unchanged at 4,522,332,324.

The company's current repurchase mandate, granted on May 27, 2025, authorized the repurchase of up to 451,560,392 shares. To date, Shandong Weigao has repurchased 19,734,400 shares, representing 4.3703% of the issued shares at the mandate's grant date. A moratorium on new share issues or treasury share sales is in effect until December 20, 2025.